Oric Pharmaceuticals, Inc. (ORIC) Q1 2024 Earnings
ORIC·Reported May 6, 2024·Before market open
Diluted EPS came in at $-0.37, beat the $-0.44 consensus by $0.07.
Diluted EPS
$-0.37beat by $0.07
Consensus: $-0.44
Financial Snapshot
Trailing eight quarters through Q1 2024
Q1 2024 Earnings FAQ
Common questions about Oric Pharmaceuticals, Inc.'s Q1 2024 earnings report.
Oric Pharmaceuticals, Inc. (ORIC) reported Q1 2024 earnings on May 6, 2024 before market open.
Oric Pharmaceuticals, Inc. reported diluted EPS of $-0.37 for Q1 2024.
EPS beat the consensus estimate of $-0.44 by $0.07.
You can read the 10-Q periodic report (0000950170-24-053582) directly on SEC EDGAR. The filing index links above go to sec.gov.